Drug and Alcohol Rehabilitation: Novel in Vitro Efficiency of Chitosan Biomolecule Against Trichomonas Gallinae.

Novel in Vitro Efficiency of Chitosan Biomolecule against Trichomonas gallinae.

Filed under: Drug and Alcohol Rehabilitation

Iran J Parasitol. 2012; 7(1): 92-6
Tavassoli M, Imani A, Tajik H, Moradi M, Pourseyed Sh

Development of new natural agents for parasitic diseases treatment has unexpectedly increased to overcome effectively against emergence and re-emergence of parasitic diseases, the appearance of drug resistant organisms and toxic side effects of current agents. The aim of the study was to evaluate antiprotozoal activities of chitosan biomolecule on trophozoites of Trichomonas gallinae.The antitrichomonal activity of various low molecular weight chitosan concentrations including 125, 250, 500 and 1250 µg ml(-1) against T. gallinae trophozoites cultured in trypticase-yeast extract-maltose medium supplemented with heat-inactivated cold horse serum was evaluated in vitro. Samples containing medium without chitosan were also assayed as controls.The mortality rates at 0, 3 and 6 h post treatment with all concentrations were significantly different from control group (P<0.05). Treated trophozoites showed more susceptibility to the highest concentration reaching mortality rate of 100% at 3h post inoculation. However, at this time, results for 125, 250 and 500 µg ml(-1) were 93%, 95% and 96.7%, respectively.The results demonstrate that the application of chitosan biomolecule is a promising option for treatment of trichomoniasis in pigeons. HubMed – drug


ABCB1 4036A>G and 1236C>T Polymorphisms Affect Plasma Efavirenz Levels in South African HIV/AIDS Patients.

Filed under: Drug and Alcohol Rehabilitation

Front Genet. 2012; 3: 236
Swart M, Ren Y, Smith P, Dandara C

The ABCB1 gene encodes P-glycoprotein, an ATP-dependent drug efflux pump, which is responsible for drug transport across extra- and intra-cellular membranes. The variability in the expression of ABCB1 may contribute to variable plasma efavirenz concentration which results in variability in the levels of suppression of the human immunodeficiency syndrome virus (HIV). The aim of the study was to evaluate the role of polymorphisms in ABCB1 gene on plasma efavirenz levels and treatment response in the form of change in viral load and CD-4 cell count in HIV/AIDS patients receiving efavirenz-containing highly active antiretroviral treatment regimens. Two hundred and eighty-two HIV-infected patients were recruited from Themba Lethu Clinic in Johannesburg and plasma efavirenz drug concentration levels were measured using LC-MS/MS. SNaPshot was used to genotype five known ABCB1 single nucleotide polymorphisms (SNPs). Genotype-phenotype correlations were computed. The ABCB1 4036A/G and 4036G/G genotypes were significantly associated with low plasma efavirenz concentrations (P?=?0.0236), while the ABCB1 1236C/T and 1236T/T genotypes were associated with high efavirenz concentrations (P?=?0.0282). A haplotype ABCB1 T-G-T-A is reported that is associated with significantly increased plasma efavirenz levels. This is the first report on 61A>G, 2677G>T/A, and 4036A>G SNPs in the South African population. ABCB1 plays a role in determining the plasma concentrations of efavirenz and should be taken into account in future design of assays for genotype-based dosing of efavirenz-containing regimens.
HubMed – drug



Car Donation – Denise Lodde – Report: Clunkers to Cash Producer: Denise Lodde Reporter Denise Lodde recently donated her car to Teen Challenge Farm, a faith based drug and alcohol rehabilitation program for men. www.tcfarm.org www.teenchallenge.ca/donate_car


Related Drug And Alcohol Rehabilitation Information…